Targeting of GSK-3β by miR-214 to facilitate gastric cancer cell proliferation and decrease of cell apoptosis
H.-L. Li, S. Liang, J.-H. Cui, G.-Y. Han The 2nd Department of General Surgery, Hongqi Hospital Affiliated to Mudanjiang Medical University, Mudanjiang, Heilongjiang, China.
Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, “Targeting of GSK-3β by miR-214 to facilitate gastric cancer cell proliferation and decrease of cell apoptosis, by H.-L. Li, S. Liang, J.-H. Cui, G.-Y. Han, published in Eur Rev Med Pharmacol Sci 2018; 22 (1): 127-134–DOI: 10.26355/eurrev_201801_14109–PMID: 29364479” has been withdrawn.
The Publisher apologizes for any inconvenience this may cause.
https://www.staging.europeanreview.org/article/14109
Free PDF DownloadThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
To cite this article
H.-L. Li, S. Liang, J.-H. Cui, G.-Y. Han
Targeting of GSK-3β by miR-214 to facilitate gastric cancer cell proliferation and decrease of cell apoptosis
Eur Rev Med Pharmacol Sci
Year: 2020
Vol. 24 - N. 14
Pages: 7574-7574
DOI: 10.26355/eurrev_202007_22245